Boehringer Ingelheim Investigational Site
Hamilton, Ontario L8N 1Y2
0 studies enrolling now · 4 studies all time
What they study most
Arthritis, Rheumatoid, Atrial Fibrillation, Diabetes Mellitus, Type 2, Hypertension, Pulmonary Disease, Chronic Obstructive
Studies at this site
- Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa — Completed
- Tiotropium / Respimat One-Year Study — Completed
- SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed
- A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed